NCBI PubMed Central
open access
An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Remdesivir for 5 or 10 Days in Patients With Severe Covid-19#391184
- Observational Study in COVID-19 Patients Treated With Remdesivir#1044671
- Infliximab to Treat Non-Infectious Scleritis#1030750
- ESICM UNITE COVID-19 Project (UNITE-COVID)#1125401
- Favipiravir in High-risk COVID-19 Patients#1075720
Record · ID 297499
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive